Our study revealed that supplementation with 1-kestose mitigated development of glucose intolerance and modified plasma insulin levels in T2D model rats, in association with increased cecal butyrate concentrations via alterations in microbiota communities. Here, INS is linked to type 2 diabetes mellitus.